Workshop on primary progressive multiple sclerosis: meeting summary

Stevenson VL , Miller DH , Leary SM , et al. One year follow up study of primary and transitional progressive multiple sclerosis . J Neurol Neurosurg Psychiatry 2000; 68: 713-718 .

Cottrell DA , Kremenchutzky M , Rice GPA , et al. The natural history of multiple sclerosis: a geographically based study: 5. The clinical features and natural history of primary progressive multiple sclerosis . Brain 1999; 122: 625-639 .

McDonnell GV , Hawkins SA. Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK . J Neurol Neurosurg Psychiatry 1998; 64: 451-454 .

Pericot I , Brieva L , Marzo ME , et al. Primary and transitional multiple sclerosis follow-up. Changes in clinical forms (Abstract) . Rev Neurol 2000; 3: S223-S223 .

Kremenchutzky OM , Cottrell D , Rice G , et al. The natural history of multiple sclerosis: a geographically based study: 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation . Brain 1999; 122: 1941-1949 .

Leary SM , Stevenson VL , Miller DH , Thompson, AJ. Problems in designing and recruiting to therapeutic trials in primary progressive multiple sclerosis . J Neurol 1999; 246: 562-568 .

Camp SJ , Stevenson VL , Thompson AJ , et al. Cognitive function in primary progressive and transitional progressive multiple sclerosis. A controlled study with MRI correlates . Brain 1999; 122: 1341-1348 .

McDonnell GV , Middleton D , Graham CA , et al. Primary progressive multiple sclerosis (MS) is associated with HLA-DR2 in Northern Ireland (Abstract) . Neurology 1998; 50: A209-A210 .

Neuhaus O , Hartung H-P. In search of a disease marker: the cytokine profile of primary progressive multiple sclerosis . Mult Scler 2001; 7: 143-144 .

Killestein J , Den Drijver BF , van der Graaff WL , et al. Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease . Mult Scler 2001; 7: 145-150 .

Durán I , Martínez-Cáceres EM , Brieva L , Tintoré M , Montalban X. Similar pro- and anti-inflammatory cytokine production in the different clinical forms of multiple sclerosis . Mult Scler 2001; 7: 151-156 .

Lucchinetti CF , Bruck W , Parisi J , et al. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions: a study of 113 cases . Brain 1999; 122: 2279-2295 .

Revesz T , Kidd D , Thompson AJ , Barnard RO , McDonald WI. A comparison of the pathology of primary and secondary progressive multiple sclerosis . Brain 1994; 117: 759-765 .

Ingle GT , Stevenson VL , Miller DH , et al. Two year follow up study of primary and transitional progressive multiple sclerosis . Mult Scler 2002; 8: 108-114 .

Thompson AJ , Montalban X , Barkhof F , et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper . Ann Neurol 2000; 47: 831-835 .

McDonald WI , Compston A , Edan G , et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis . Ann Neurol 2001; 50: 121-127 .

Leary SM , Stevenson VL , Miller DH , Thompson AJ. Problems in designing and recruiting to therapeutic trials in primary progressive multiple sclerosis . J Neurol 1999; 246: 562-568 .

Kremenchutzky M , Rice GPA , Hader W , Baskerville J , Ebers GC. The natural history of multiple sclerosis: a geographically based study: 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis . Brain 1999; 122: 641-647 .